Exane Derivatives’s Equinor EQNR Stock Holding History

Exane Derivatives’s Portfolio EQNR Stock Details EQNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,000	Closed	-$153K	–	908
2021 Q3	$153K	Buy	+6,000	New	+$128K	0.04%	457

Other funds holding EQNR

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Exane Derivatives's EQNR Position: Q4 2021 in Review

Exane Derivatives sold out of Equinor (EQNR) in Q4 2021, closing a stake of 6,000 shares — an estimated $153K sold.

Exane Derivatives first reported a position in EQNR in Q3 2021 and held it in 1 quarter. The position peaked at $153K in Q3 2021. 290 funds tracked by Wall St. Rank hold EQNR as of Q4 2021.

Exane Derivatives reported no remaining Equinor position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 6,000 Equinor shares in Q4 2021, an estimated $153K.
Exane Derivatives first reported a position in Equinor in Q3 2021 and held it in 1 quarter.
Exane Derivatives's Equinor position peaked at $153K in Q3 2021.
290 funds tracked by Wall St. Rank held Equinor as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.